Effects of moxibustion on symptoms of mild cognitive impairment: protocol of a systematic review and meta-analysis.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
28 04 2020
Historique:
entrez: 1 5 2020
pubmed: 1 5 2020
medline: 13 2 2021
Statut: epublish

Résumé

Mild cognitive impairment (MCI) is considered the intermediate phase between normal age-related cognitive decline and dementia. Moxibustion has gained increased popularity for the management of MCI in China.This study aimed to evaluate the effects and safety of moxibustion on symptoms of MCI. Four English databases and six Chinese databases will be searched from their inception to October 2019: Embase, MEDLINE, Cochrane Central Register of Controlled Trials, Allied and Complementary Medicine Database, China National Knowledge Infrastructure, Chongqing VIP Chinese Science and Technology Periodical Database, Wanfang Database, SinoMed, China Doctoral Dissertations Full-text Database and the China Master's Theses Full-text Database. Only clinical randomised controlled trials and the first period in randomised cross-over trial related to moxibustion for MCI will be included. The primary outcomes include the improvement of cognitive function, as measured by validated assessment tools. The secondary outcomes include changes in the activity of daily living scale, effective rate and the incidences of adverse events. The selection of studies, data extraction and risk of bias assessment will be carried out by two independent reviewers. Review Manager V.5.3 software will be used for statistical analyses. Heterogeneity test, data synthesis and subgroup analysis will be performed if necessary. The risk of bias of included studies will be assessed by the Ethics approval is not required as no private information from individuals are collected. The results will be published in a peer-reviewed journal or disseminated in relevant conferences. CRD42018112657.

Identifiants

pubmed: 32350012
pii: bmjopen-2019-033910
doi: 10.1136/bmjopen-2019-033910
pmc: PMC7213842
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e033910

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Neurology. 2018 Jan 16;90(3):126-135
pubmed: 29282327
Complement Ther Med. 2006 Sep;14(3):213-9
pubmed: 16911902
J Pharmacol Sci. 2006;100(5):443-59
pubmed: 16799260
Acta Psychiatr Scand. 2014 Dec;130(6):439-51
pubmed: 25219393
Evid Based Complement Alternat Med. 2014;2014:783704
pubmed: 24976851
Exp Neurobiol. 2018 Feb;27(1):1-15
pubmed: 29535565
Complement Ther Med. 2009 Aug;17(4):243-6
pubmed: 19632553
Arch Neurol. 2001 Dec;58(12):1985-92
pubmed: 11735772
Psychogeriatrics. 2012 Jun;12(2):131-2
pubmed: 22712649
Semin Neurol. 2007 Feb;27(1):22-31
pubmed: 17226738
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
Lancet Neurol. 2003 Jan;2(1):15-21
pubmed: 12849297
Cochrane Database Syst Rev. 2018 Dec 21;12:CD012678
pubmed: 30575956
Evid Based Complement Alternat Med. 2016;2016:5105108
pubmed: 27293460
Syst Rev. 2012 May 30;1:25
pubmed: 22647316
J Clin Epidemiol. 2011 Apr;64(4):380-2
pubmed: 21185693
Lancet. 2000 Jan 15;355(9199):225-8
pubmed: 10675135
Evid Based Complement Alternat Med. 2013;2013:756095
pubmed: 24386005
Cochrane Database Syst Rev. 2017 Dec 19;12:CD012665
pubmed: 29256573
Lancet Neurol. 2007 Jun;6(6):501-12
pubmed: 17509485
PLoS One. 2017 Feb 7;12(2):e0170952
pubmed: 28170396
PLoS One. 2017 Jun 7;12(6):e0178688
pubmed: 28591176
Evid Based Complement Alternat Med. 2009 Mar;6(1):11-7
pubmed: 18955231
Evid Based Complement Alternat Med. 2017;2017:9854893
pubmed: 29234451
Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006104
pubmed: 16856114
J Evid Based Med. 2015 Feb;8(1):2-10
pubmed: 25594108
Sao Paulo Med J. 2017 May-Jun;135(3):309-320
pubmed: 28746664

Auteurs

Tao Zhang (T)

Department of Acupuncture and Moxibustion, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Key Laboratory of Acupuncture Neuromodulation, Beijing, China.

Lin-Peng Wang (LP)

Department of Acupuncture and Moxibustion, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Key Laboratory of Acupuncture Neuromodulation, Beijing, China.

Gui-Ling Wang (GL)

Department of Acupuncture and Moxibustion, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Key Laboratory of Acupuncture Neuromodulation, Beijing, China.

Jing-Qing Sun (JQ)

Department of Acupuncture and Moxibustion, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Key Laboratory of Acupuncture Neuromodulation, Beijing, China.

Xue-Wen Mao (XW)

Department of Acupuncture and Moxibustion, Shunyi Hospital, Beijing Traditional Chinese Medicine Hospital, Beijing, China.

Hui-Li Jiang (HL)

Acupuncture Research Center, School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China.

Bin Li (B)

Department of Acupuncture and Moxibustion, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Key Laboratory of Acupuncture Neuromodulation, Beijing, China lcz623780@126.com libin@bjzhongyi.com.

Cun-Zhi Liu (CZ)

Acupuncture Research Center, School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China lcz623780@126.com libin@bjzhongyi.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH